News & Updates

Navigating the unknowns in COVID-19 the ACP way

29 May 2020 by

In the face of the COVID-19 pandemic which has taken the world by storm, the lack of approved treatments targeted towards coronavirus has left physicians worldwide grappling with the situation. To help them navigate the black box of COVID-19 management, the ACP* has released a behemoth 28-chapter guide to arm physicians in the virus-infested battle field.

Navigating the unknowns in COVID-19 the ACP way

29 May 2020

Ammonia levels do not guide management of hepatic encephalopathy

28 May 2020

Neither the presence nor the level of ammonia influences inpatient management of hepatic encephalopathy (HE) with lactulose, which suggests that ammonia levels do not guide therapy in clinical practice, according to a study.

Ammonia levels do not guide management of hepatic encephalopathy

28 May 2020

Tenofovir delivers better protection against HCC than entecavir in HBV patients

28 May 2020 by

Persistent hepatitis B virus (HBV) replication contributes to an increased risk of hepatocellular carcinoma (HCC), and suppressing this replication with tenofovir disoproxil fumarate yields greater HCC risk reduction than with entecavir, according to the results of a meta-analysis.

Tenofovir delivers better protection against HCC than entecavir in HBV patients

28 May 2020

Doctors give PPIs a bad name, recommends discontinuation even in UGIB

27 May 2020

The perception that proton pump inhibitors (PPIs) cause multiple serious adverse effects (AEs) is supported by many internists, who then recommend treatment cessation even in patients at high risk for upper gastrointestinal bleeding (UGIB), reveals a study.

Doctors give PPIs a bad name, recommends discontinuation even in UGIB

27 May 2020

Transperineal ultrasound useful for predicting endoscopic, histological healing in ulcerative colitis

27 May 2020 by

Bowel wall thickness in transperineal ultrasound correlates well with both endoscopic severity and histological activity in patients with ulcerative colitis (UC), as shown in a study. The combination of transperineal and transabdominal ultrasound enables visualization of the entire colorectum and is an ideal modality to monitor disease course through a treat‐to‐target strategy.

Transperineal ultrasound useful for predicting endoscopic, histological healing in ulcerative colitis

27 May 2020

Women have lower NAFLD risk than men but more likely to progress to advanced fibrosis

26 May 2020

Women are less likely to develop nonalcoholic fatty liver disease (NAFLD), although they are at higher risk of progression to advanced fibrosis once NAFLD is established as compared with men, a study reports.

Women have lower NAFLD risk than men but more likely to progress to advanced fibrosis

26 May 2020

Tranexamic acid cuts mortality in patients with upper GI bleeding

25 May 2020

Treatment with tranexamic acid appears to improve survival outcome in patients with upper gastrointestinal (GI) bleeding, according to the results of a systematic review and meta-analysis.

Tranexamic acid cuts mortality in patients with upper GI bleeding

25 May 2020

Capsule endoscopy feasible for iron deficiency anaemia diagnosis

24 May 2020

The use of capsule endoscopy (CE) appears to be effective in the diagnosis of iron deficiency anaemia (IDA), yielding a 33.9-percent yield in this study, with 65.8 percent of patients undergoing further workup and 12.7 percent requiring therapeutic intervention.

Capsule endoscopy feasible for iron deficiency anaemia diagnosis

24 May 2020

Pembrolizumab + SOX may benefit stomach cancer patients

22 May 2020 by

The combination of the monoclonal antibody pembrolizumab and a chemotherapy (CT) regimen consisting of S-1 plus oxaliplatin (SOX) showed encouraging efficacy and manageable safety as first-line treatment in patients with advanced gastric/gastroesophageal junction (G/GEJ) cancer, according to the cohort 1 results of the Japanese KEYNOTE-659* study.

Pembrolizumab + SOX may benefit stomach cancer patients

22 May 2020

Prophylactic oral antibiotics may reduce surgical site infections

21 May 2020 by

The administration of oral antibiotics – without mechanical bowel preparation – one day before colon surgery may reduce the risk of surgical site infections, according to results of the ORALEV* trial.

Prophylactic oral antibiotics may reduce surgical site infections

21 May 2020

News & Updates

Filter by Specialty:

Specialty:

Navigating the unknowns in COVID-19 the ACP way

Navigating the unknowns in COVID-19 the ACP way

Ammonia levels do not guide management of hepatic encephalopathy

Ammonia levels do not guide management of hepatic encephalopathy

Tenofovir delivers better protection against HCC than entecavir in HBV patients

Tenofovir delivers better protection against HCC than entecavir in HBV patients

Doctors give PPIs a bad name, recommends discontinuation even in UGIB

Doctors give PPIs a bad name, recommends discontinuation even in UGIB

Transperineal ultrasound useful for predicting endoscopic, histological healing in ulcerative colitis

Transperineal ultrasound useful for predicting endoscopic, histological healing in ulcerative colitis

Women have lower NAFLD risk than men but more likely to progress to advanced fibrosis

Women have lower NAFLD risk than men but more likely to progress to advanced fibrosis

Tranexamic acid cuts mortality in patients with upper GI bleeding

Tranexamic acid cuts mortality in patients with upper GI bleeding

Capsule endoscopy feasible for iron deficiency anaemia diagnosis

Capsule endoscopy feasible for iron deficiency anaemia diagnosis

Pembrolizumab + SOX may benefit stomach cancer patients

Pembrolizumab + SOX may benefit stomach cancer patients

Prophylactic oral antibiotics may reduce surgical site infections

Prophylactic oral antibiotics may reduce surgical site infections